Seraphim Space Investment Trust (LSE: SSIT) leans on ICEYE re-rating and SpaceX IPO tailwind to consolidate FTSE 250 entry
Read More Healthcare Industry News A $560m test for the diabetes device market as MiniMed prepares to trade on Nasdaq MiniMed prices its IPO at $20 per share, raising $560M as Medtronic plc spins out its diabetes unit. Discover what the move means for the diabetes technology market. byVenkateshMarch 6, 2026